IV Fluid Monitoring Devices Market Size

  • Report ID: 5528
  • Published Date: Nov 27, 2025
  • Report Format: PDF, PPT

IV Fluid Monitoring Devices Market Outlook:

IV Fluid Monitoring Devices Market size was over USD 5.12 billion in 2025 and is poised to exceed USD 10.36 billion by 2035, growing at over 7.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of IV fluid monitoring devices is estimated at USD 5.46 billion.

The major element to influences the market expansion is the growing prevalence of hospital-acquired infection. In 2022, it was estimated by WHO that, at least one healthcare-associated infection (HAI) will be acquired by seven patients in high-income nations and fifteen patients in low- and middle-income countries out of every 100 patients in acute-care hospitals during their hospital stay. Approximately 10% of impacted patients will pass away due to their HAI. Hence, the market revenue for IV fluid monitoring devices is set to increase in order to reduce hospital acquired infection.

Additionally, the majority of pharmaceutical and medical device companies have focused on integrating cutting-edge technologies into infusion systems in order to enhance the efficacy, safety, and efficiency of drugs while decreasing the possibility of unfavorable reactions brought on by an overdose or underdose. Therefore, this factor is also set to drive the IV fluid monitoring devices market expansion.


IV Fluid Monitoring Devices Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of IV fluid monitoring devices is estimated at USD 5.46 billion.

The global IV fluid monitoring devices market size was more than USD 5.12 billion in 2025 and is anticipated to grow at a CAGR of over 7.3%, reaching USD 10.36 billion revenue by 2035.

In the IV fluid monitoring devices market, North America is expected to command a 30% share by 2035, supported by escalating chronic disease prevalence and the rising integration of smart medical robotics that minimize medication errors.

Key players in the market include Baxter International Inc., Pfizer Inc., ICU Medical Inc., Unilife Corporation, Amedra Pharmaceuticals Pvt. Ltd., Sanofi, Biogen Inc., Cole Parmer Instrument Co. LLC, Datrend Systems Inc., GMC-INSTRUMENTS GROUP.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos